ReviewThe development and spread of drug-resistant malaria
References (39)
- et al.
Trans. R. Soc. Trop. Med. Hyg.
(1990) Lancet
(1988)Trans. R. Soc. Trop. Med. Hyg.
(1989)Lancet
(1990)- et al.
Trans. R. Soc. Trop. Med. Hyg.
(1990) - et al.
Lancet
(1989) Lancet
(1989)Trans. R. Soc. Trop. Med. Hyg.
(1984)Lancet
(1988)Parasitology Today
(1988)
Dtsch. Med. Wochenschr.
Mem. Inst. Oswaldo Cruz
Bull. WHO
Tech. Rep. Ser. No. 711
Bull. Soc. Pathol. Exot.
Am. J. Trop. Med. Hyg.
Nature
Southeast Asian J. Trop. Med. Public Health
Cited by (175)
A literature review on traditional herbal medicines for malaria
2020, South African Journal of BotanyDynamics of an age-structured two-strain model for malaria transmission
2015, Applied Mathematics and ComputationCitation Excerpt :Treatment failure (due to incorrect dosing, non-compliance with duration of dosing regimen, poor drug quality, drug interactions, poor or erratic absorption and misdiagnosis etc.). Anti-malaria drug resistance clearly poses major challenges to the global effort to effectively control the spread of malaria (or to eradicate the disease) [6,60]. Consequently, it is important to study the qualitative impact of treatment (using the currently-available anti-malaria drugs) on the transmission dynamics of malaria in a population.
Design, economical synthesis and antiplasmodial evaluation of vanillin derived allylated chalcones and their marked synergism with artemisinin against chloroquine resistant strains of Plasmodium falciparum
2014, European Journal of Medicinal ChemistryCitation Excerpt :Almost all these deaths are caused by Plasmodium falciparum, one of the four species of malaria parasites in humans [2]. The principal reason hampering malaria control is the emergence of resistance by P. falciparum strains to the first-line antimalarial drugs like chloroquine [3,4]. Natural products have always remained in focus for the discovery of new drug leads intended for the treatment of human diseases [5].